2019-nCOV IgG/IgM Rapid Test Fabrica (Per totum sanguinem/Serum/Plasma)
.Sensibilitas et Specificatio.
Testis enim Igg;
| Methodus | RT-PCR | Summa Proventuum | ||
| 2019-nCOV IgG/IgM Celeri Test Fabrica (Integrum sanguinem/Serum/Plasma) | Proventus | Positivum | Negative | |
| Positivum | 233 | 2 | 235 | |
| Negative | 25 | 287 | 312 | |
| Summa Proventuum | 258 | 289 | 547 | |
Sensus relativus: 233/258=90.31%(95%CI*:86.04%-93.40%)
Relativum Specificatio:287/289=99.31% (95%CI*:97.34%-99.98%)
Accuracy:520/547=95.06% (95%CI*: 92.89%-96.61%)
* Fiducia Intervallum
Nam Igm temptationis
| Methodus | RT-PCR | Summa Proventuum | ||
| 2019-nCOV IgG/IgM Celeri Test Fabrica (Integrum sanguinem/Serum/Plasma) | Proventus | Positivum | Negative | |
| Positivum | 223 | 7 | 230 | |
| Negative | 35 | 282 | 317 | |
| Summa Proventuum | 258 | 289 | 547 | |
Sensus relativus: 223/258=86.43% (95%CI*:81.68%-90.11%)
Relativum Specificatio: 282/289=97.58% (95%CI*: 94.99%- 98.92%)
Accuracy:505/547=92.32% (95%CI*: 89.76%-94.29%)
* Fiducia Intervallum
.Directiones ad usum.
Epistulam tuam hic scribe et mitte nobis
